High CEACAM1 expression significantly correlates with longer recurrence-free and overall survival as shown at mRNA and protein levels in two independent cohorts comprising material from 517 and 210 ovarian cancer patients, respectively. Here, CEACAM1 is linked to ovarian cancer.